ÍøºìºÚÁÏ

Skip to main content
(352) 265-0820

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh
(352) 265-0820 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

379 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2021

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Bioprosthetic Valves-A Systematic Review and Meta-analysis.

The Journal of innovations in cardiac rhythm management

•

2021

Oral Anticoagulation Use in High-Risk Patients Is Improved by Elimination of False-Positive and Inactive Atrial Fibrillation Cases.

The American journal of medicine

•

2021

Risks of adverse events in patients with orthostatic intolerance undergoing surgery with general anesthesia

Clinical Autonomic Research

2020

A Multimorbidity-Based, Risk-Stratified Reanalysis of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Trial.

Drugs & aging

•

2020

Aspirin for Primary Atherosclerotic Cardiovascular Disease Prevention as Baseline Risk Increases: A Meta-Regression Analysis.

The American journal of medicine

•